Skip to main content
. 2013 Apr 2;8(4):e60113. doi: 10.1371/journal.pone.0060113

Figure 4. Several types of biomarkers for SMA-MAP analytes.

Figure 4

SMA biomarkers were identified for their regression to motor function and non-motor outcome measures. The analytes have been confirmed and validated to different degrees and will require more validation in prospective, longitudinal studies to determine their utility as biomarkers for disease progression and pharmacodynamic response.